Cargando…
COVID-19 vaccines: where we stand and challenges ahead
In the eleven months elapsed since the identification of the SARS-CoV-2 virus and its genome, an exceptional effort by the scientific community has led to the development of over 300 vaccine projects. Over 40 are now undergoing clinical evaluation, ten of these are in Phase III clinical trials, thre...
Autores principales: | Forni, Guido, Mantovani, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818063/ https://www.ncbi.nlm.nih.gov/pubmed/33479399 http://dx.doi.org/10.1038/s41418-020-00720-9 |
Ejemplares similares
-
Long Covid: where we stand and challenges ahead
por: Mantovani, Alberto, et al.
Publicado: (2022) -
Gut microbiota in ischemic stroke: Where we stand and challenges ahead
por: Long, Jiaxin, et al.
Publicado: (2022) -
Acute neuromuscular syndromes with respiratory failure during COVID-19 pandemic: Where we stand and challenges ahead
por: Galassi, Giuliana, et al.
Publicado: (2022) -
Heritage Conservation Future: Where We Stand, Challenges Ahead, and a Paradigm Shift
por: Otero, Jorge
Publicado: (2021) -
Schistosomiasis vaccines: where do we stand?
por: Tebeje, Biniam Mathewos, et al.
Publicado: (2016)